Circle Has Explored Potential $5B Sale to Coinbase or Ripple Instead of IPO: Report
Stablecoin issuer Circle, which filed for an initial public offering (IPO) last month, has explored the alternative of a sale to crypto exchange Coinbase (COIN) or payments company Ripple, according to a Monday report by Fortune.
The New York-based issuer of USDC, the second-largest stablecoin, took part in informal talks over a potential sale from which it was seeking at least $5 billion, Fortune reported, citing people who asked not to be identified.
This figure would be line with the company's valuation by investment banks JPMorgan and Citi, which Circle had hired to help with the IPO.
Coinbase holds a minority share in Circle, and the two companies share revenue from USDC's reserve interest income. Ripple recently debuted its own stablecoin, RLUSD. An offer by Ripple to buy Circle was rejected, Bloomberg reported last month.
Circle said in an emailed statement that it "is not for sale," and remains committed to going public, Fortune said. The company aborted a previous attempt at going public via a special purpose acquisition company (SPAC) merger in 2021.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
43 minutes ago
- Yahoo
Why Wall Street's Dr. Doom now wants to be Dr. Boom
Nouriel Roubini, who's been known as "Dr. Doom" for 17 years, is feeling more upbeat. The economist has scaled back his recession call and thinks the US is headed for an investment boom. He told BI there are three things that have driven his newfound optimism. Wall Street has been calling him "Dr. Doom" for 17 years, but Nouriel Roubini — the economist famous for his persistently bearish and frequently dystopian takes on the world economy — is sounding surprisingly positive lately. He's rescinded his earlier call for a recession, and now sees a US tech and artificial intelligence investment boom unfolding that will uplift the economy through the rest of this decade. By 2030, Roubini thinks economic growth in the US will double from around 2% to 4%, while productivity growth surges from around 1.9% to 3%. The stock market is also likely to climb higher, he told Business Insider in an interview, predicting the S&P 500 would see high single-digit percentage growth in 2025, on par with its historical return. It's a sharp turnaround from the gloomy forecasts he' is known for. Roubini told BI the nickname started to stick in 2008, when the New York Times referred to him as "Dr. Doom" after he correctly called the Great Financial Crisis, he told BI. "Even before, I always said I'm not Dr. Doom and I'm Dr. Realist, first of all," Roubini said. He said that he's made numerous forecasts that were more bullish than the consensus throughout the years when the evidence lines up. "So I don't know why people think that I'm always Dr. Doom. It's not the case." His outlook, though, has brightened considerably since 2022. Back then, he appeared on TV and penned op-eds warning of a coming stagflationary debt crisis. At the time, he described the turmoil he saw looming as an all-in-one financial crisis involving spiraling debt levels, soaring inflation, and a severe recession. Roubini told BI there are a few things that have gotten him to change his tune. Roubini says he began to hear the murmurs of the AI revolution well before ChatGPT went viral at the end of 2022. In his 2022 book, "Megathreats," he acknowledged the potential for artificial intelligence to significantly boost economic growth and serve as a major tailwind for markets. That's become a reality way faster than Roubini expected, and a major reason he's become more bullish, he told BI. He believes the economy could start to reap the growth and productivity benefits of AI in the next several years, particularly as humanoid robots enter the mainstream. A breakthrough in fusion energy would be another bullish force for the economy, Roubini said. Fusion energy hasn't been achieved yet, but tech firms are pouring vast sums of money into making it happen. Chevron and Google contributed to a more than $150 million funding round this week for TAE Technologies, a fusion energy company that plans to have a working prototype power plant by the early 2030s. Type One Energy, another fusion energy firm, also plans to roll out a power plant by the middle of the next decade. "We're not in an AI winter anymore. We had the fusion winter for 40 years. We're not anymore," Roubini said, pointing to the stagnation in tech and fusion energy development is the past. "Now it's happening." President Donald Trump's tariffs may not be as harmful to the US economy as some investors think, Roubini says. He thinks it's more likely that markets will throw a tantrum and force Trump to walk back his most aggressive policies. That's already happened a few times this year. Roubini pointed to sharp sell-offs in the bond market that preceded Trump's 90-day pause of his "Liberation Day" tariffs, and the softening of his tone regarding firing Jerome Powell. "That means the bond vigilantes are the most powerful people in the world," Roubini said. "The instincts might be very bad, but then, markets are unforgiving," he added of policymakers. Roubini speculates that tariffs on China, for instance, could wind up somewhere around 39%, well-below the 145% tariff rate Trump proposed earlier in the year. Meanwhile, AI, quantum computing, and other tech advancements in the US can more than offset the impact of the trade war, Roubini said. Tariffs are expected to drag down GDP growth by 0.06% a year through 2035, according to estimates from the Congressional Budget Office. It's a fraction of the 2 percentage point increase in growth Roubini expects to see by the end of the decade. Roubini now pegs the odds of a recession to just around 25%. Even if the US enters a downturn this year, Roubini says he expects it to be shallow and short, as the Fed can cut interest rates to boost the economy, while tech powers growth over the long-run. That's not to say Dr. Doom has shed all of his bearish views. Roubini says many of the things he feared several years ago — stagflation, spiraling government debt levels, and rising geopolitical conflict — still loom. He rattled off a list of potential risks the US could conceivably face in the future: migration controls fueling stagflation in the economy, the US dollar collapsing in value, and China and the US not reaching a trade agreement and seeing an escalating cold war, to name a few scenarios. "So there's plenty of stuff in the world that can go wrong," he said. Read the original article on Business Insider Sign in to access your portfolio
Indianapolis Star
an hour ago
- Indianapolis Star
See Purdue's 50-year plan to transform downtown Indianapolis campus with high-rises
Over the next 50 years, Purdue University plans to transform its downtown Indianapolis campus into an urban hub with high-rise buildings serving up to 15,000 students, according to a new master plan. Today, Purdue's 28-acre sliver of land wedged between Indiana Avenue and Michigan Street on downtown's west side — roughly the same acreage as the parcel on which Lucas Oil Stadium and its south parking lot sit — is home to three parking garages and five expansive parking lots. A conceptual master plan approved by Purdue's Board of Trustees June 6 envisions 16 new buildings on that site, featuring 4.5 million square feet and about 3,500 student beds. With leasing agreements at nearby apartments, Purdue expects to offer students more than 5,300 beds downtown. The plan foresees an increase in Purdue's student enrollment in Indianapolis from about 2,800 in fall 2024 to 15,000 by fall 2075. Despite the dense development, the plan sets aside about 60% of the downtown acreage for open spaces where students can gather and walk, according to Maryland-based architecture firm Ayers Saint Gross, which designed the 50-year master plan. Construction on the campus' main building, the 15-story Academic Success Building near the intersection of West and Michigan streets, began this April. The $187 million facility with classrooms, lab space, dining halls and student housing will be complete around May 2027. The long-term plan comes as Purdue and Indiana University in Indianapolis jostle for position on the west side of downtown following the 2024 split of the two schools' joint urban campus, IUPUI. As Purdue updates its plans, IU has allotted hundreds of millions of dollars to build multiple major facilities, including an 11-story School of Medicine building and a 4,500-seat athletics center, on its downtown campus in the next few years. IUPUI split: Indiana Ave. fell as IUPUI rose. After Purdue and IU split, can they help renew the Avenue? After the IUPUI division, IU retains most of the 536-acre downtown campus and enrolled more than 25,000 students in fall 2024. IU also owns the 28-acre wedge of land where Purdue will expand between Indiana Avenue to the north, Michigan Street to the south and Blake Street to the west. Purdue has signed a 100-year lease to use the property. Purdue is expanding into Indiana's capital city in part to ease the strain on housing and other facilities at the West Lafayette campus, which now enrolls an all-time high of more than 55,000 students. University leaders have also announced partnerships with Indianapolis-based science and engineering firms like animal health company Elanco and race car manufacturer Dallara. 'Rather than a single hub, Purdue is weaving into the fabric of the city's innovation and industry corridors," David Umulis, Purdue's senior vice provost for Indianapolis, said in a statement, "expanding from downtown all the way to the northwest side of Indianapolis."
Associated Press
an hour ago
- Associated Press
RBGLY Investors Have Opportunity to Lead Reckitt Benckiser Group PLC Securities Fraud Lawsuit
NEW YORK, June 7, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of American Depositary Shares ('ADSs') of Reckitt Benckiser Group PLC (OTC: RBGLY) between January 13, 2021 through July 28, 2024, both dates inclusive (the 'Class Period'). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 4, 2025. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. So What: If you purchased Reckitt ADSs you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. What to do next: To join the Reckitt class action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 4, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. Details of the case: According to the lawsuit, during the Class Period, defendants failed to warn investors and consumers: (1) that preterm infants were at an increased risk of developing necrotizing enterocolitis ('NEC') by consuming Reckitt's cow's milk-based formula, Enfamil; (2) of the attendant impact on Reckitt's sales of Enfamil and Reckitt's exposure to legal claims; and (3) as a result of the above, defendants' positive statements about Reckitt's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Reckitt action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] View original content to download multimedia: SOURCE THE ROSEN LAW FIRM, P. A.
